Biosign Technologies Inc. is a manufacturer and vendor of medical devices, healthcare information systems and related services. It delivers cloud-based systems for non-invasive monitoring of common health risks associated with blood pressure, life style, medication and chronic disease management. The Company provides automated, software enabled health information solutions, including the Pulsewave Health Monitor and the Healthanywhere Patient monitoring / self-care platform. The Company's Pulsewave Health Monitor solution enables Pulse data collection for cardiovascular clinical decision support and self-care, while its Healthanywhere solution offers remote patient monitoring and patient centered care management. In August 2014, the Company announced the completion of share purchase agreement with 3282909 Nova Scotia Ltd, under which it has sold 12.5% of its 51% ownership interest of MECK Medical GmbH.